Biomerica Stock Performance
| BMRA Stock | USD 0.56 0.07 11.11% |
Biomerica holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 5.52, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomerica will likely underperform. Use Biomerica total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on Biomerica.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Biomerica are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Biomerica sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 9.7 M |
Biomerica |
Biomerica Relative Risk vs. Return Landscape
If you would invest 36.00 in Biomerica on November 2, 2024 and sell it today you would earn a total of 20.00 from holding Biomerica or generate 55.56% return on investment over 90 days. Biomerica is currently generating 1.5016% in daily expected returns and assumes 14.9691% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Biomerica, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biomerica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomerica's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomerica, and traders can use it to determine the average amount a Biomerica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1003
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BMRA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.97 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.5 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Biomerica is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomerica by adding it to a well-diversified portfolio.
Biomerica Fundamentals Growth
Biomerica Stock prices reflect investors' perceptions of the future prospects and financial health of Biomerica, and Biomerica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomerica Stock performance.
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.39 | ||||
| Profit Margin | (1.12) % | ||||
| Operating Margin | (0.76) % | ||||
| Current Valuation | 9.81 M | ||||
| Shares Outstanding | 16.82 M | ||||
| Price To Earning | (25.64) X | ||||
| Price To Book | 2.26 X | ||||
| Price To Sales | 1.87 X | ||||
| Revenue | 5.42 M | ||||
| EBITDA | (5.99 M) | ||||
| Cash And Equivalents | 6.08 M | ||||
| Cash Per Share | 0.45 X | ||||
| Total Debt | 785 K | ||||
| Debt To Equity | 0.16 % | ||||
| Book Value Per Share | 0.32 X | ||||
| Cash Flow From Operations | (5.36 M) | ||||
| Earnings Per Share | (0.37) X | ||||
| Total Asset | 9.25 M | ||||
| Retained Earnings | (48.2 M) | ||||
| Current Asset | 4.77 M | ||||
| Current Liabilities | 445 K | ||||
About Biomerica Performance
By analyzing Biomerica's fundamental ratios, stakeholders can gain valuable insights into Biomerica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomerica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomerica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Biomerica operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.Things to note about Biomerica performance evaluation
Checking the ongoing alerts about Biomerica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomerica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomerica is way too risky over 90 days horizon | |
| Biomerica has some characteristics of a very speculative penny stock | |
| Biomerica appears to be risky and price may revert if volatility continues | |
| Biomerica has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 5.42 M. Net Loss for the year was (5.98 M) with profit before overhead, payroll, taxes, and interest of 446 K. | |
| Biomerica currently holds about 6.08 M in cash with (5.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45. |
- Analyzing Biomerica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomerica's stock is overvalued or undervalued compared to its peers.
- Examining Biomerica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomerica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomerica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomerica's stock. These opinions can provide insight into Biomerica's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets |